Emergent Drug Panel-Version 2 (EDP-V2) Kit
Key Takeaways
- Full and open competition - all businesses eligible to bid
- Work to be performed in ATLANTA, GA
- Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Advance notice of upcoming solicitation
Contract Details
- Notice ID
- 000HCNBG-2026-99823
- Opportunity Type
- Presolicitation
- Sub-Agency
- CENTERS FOR DISEASE CONTROL AND PREVENTION
- Office
- CDC OFFICE OF ACQUISITION SERVICES
- Posted Date
- Wednesday, September 9, 2026
- Response Deadline
- Monday, September 14, 2026
- PSC Code
- 6550
- Set-Aside
- Full & Open Competition
- Place of Performance
- ATLANTA, GA, 30333
- Status
- Active
Description
The Centers for Disease Control and Prevention intends to award a sole source firm fixed price contract to Cayman Chemical Company, Inc. for the design, manufacture, distribution, and associated laboratory support services for the Emergent Drug Panel-Version 2 (EDP-V2) Kit, a new product line addition within CDC's Traceable Opioid Material (TOM) Kit program, and continued distribution, product support, and data collection services for existing Emergent Drug Panel (EDP) Kit products. The anticipated period of performance is 09/30/2026 through 09/29/2027. The requirement will include four option years for design and manufacture of additional kits as well as continuous distribution. The Government intends to solicit and negotiate with only one source under the authority of FAR 12.102(a). CDC
Why This Opportunity Matters
HEALTH AND HUMAN SERVICES, DEPARTMENT OF is actively seeking qualified contractors for research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology) in ATLANTA, GA.
Similar Opportunities
Browse Related
Looking for more opportunities?
Browse our full directory of government contracts
